Kinnevik has invested USD 100 million in Oviva, acquiring a 13% stake in the profitable European digital health platform focused on managing weight-related and chronic illnesses.
Target Company Overview
Kinnevik recently invested USD 100 million to acquire a 13% ownership stake in Oviva, a prominent European digital health platform dedicated to managing weight-related and chronic illnesses. Oviva aims to revolutionize the care of over 200 million individuals across Europe through its innovative digital care solutions, reflecting the company's commitment to delivering impactful health technology.
This investment is part of Kinnevik's broader strategy to enhance its portfolio by focusing on mature, profitable, and stable assets. Despite setbacks in certain sectors, the operational performance of Kinnevik's companies remains solid, underscoring the potential for growth in the health tech space, particularly for a company like Oviva.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The digital health industry in Europe has gained significant traction in recent years, buoyed by technological advancements and an increased demand for accessible healthcare solutions. The rising in
Similar Deals
ARCHIMED → RehabWorks and Primo Group s.r.l.
2023
Not specified → Posos
2023
Prosperity7 Ventures → Insilico Medicine
2023
PC Capital Development Fund II, L.P. → Polar
2023
Kinnevik
invested in
Oviva
in 2025
in a Growth Equity & Expansion Capital deal
Disclosed details
Transaction Size: $100M